These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 25409905)
1. Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905 [TBL] [Abstract][Full Text] [Related]
2. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation. Yao H; Veine DM; Fay KS; Staszewski ED; Zeng ZZ; Livant DL Breast Cancer Res Treat; 2011 Jan; 125(2):363-75. PubMed ID: 20300829 [TBL] [Abstract][Full Text] [Related]
3. Licochalcone E present in licorice suppresses lung metastasis in the 4T1 mammary orthotopic cancer model. Kwon SJ; Park SY; Kwon GT; Lee KW; Kang YH; Choi MS; Yun JW; Jeon JH; Jun JG; Park JH Cancer Prev Res (Phila); 2013 Jun; 6(6):603-13. PubMed ID: 23625311 [TBL] [Abstract][Full Text] [Related]
4. Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Matsui J; Funahashi Y; Uenaka T; Watanabe T; Tsuruoka A; Asada M Clin Cancer Res; 2008 Sep; 14(17):5459-65. PubMed ID: 18765537 [TBL] [Abstract][Full Text] [Related]
5. Synergy between a collagen IV mimetic peptide and a somatotropin-domain derived peptide as angiogenesis and lymphangiogenesis inhibitors. Koskimaki JE; Lee E; Chen W; Rivera CG; Rosca EV; Pandey NB; Popel AS Angiogenesis; 2013 Jan; 16(1):159-70. PubMed ID: 23053781 [TBL] [Abstract][Full Text] [Related]
6. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model. Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A. Lee E; Koskimaki JE; Pandey NB; Popel AS Neoplasia; 2013 Feb; 15(2):112-24. PubMed ID: 23441126 [TBL] [Abstract][Full Text] [Related]
8. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases. J Hematol Oncol; ; . PubMed ID: 28629427 [TBL] [Abstract][Full Text] [Related]